We determined the antimicrobial susceptibility of 90 clinical isolates of Stenotro-phomonas maltophilia collected in 2009 at a tertiary care hospital in Korea. Trime-thoprim-sulfamethoxazole, minocycline, and levofloxacin were active against most of the isolates tested. Moxifoxacin and tigecycline were also active and hold promise as therapeutic options for S. maltophilia infections.
|Number of pages||3|
|Journal||Yonsei Medical Journal|
|State||Published - Mar 2012|
- Antimicrobial susceptibility
- Stenotrophomonas maltophilia